Pre-Eclampsia - Smoking Study
Smoking Protects Against Pre-Eclampsia: The Potential Role of the Cholinergic Anti-inflammatory Pathway
Protocol ID
Protocol Description
The purpose of this study is to investigate why cigarette smoking (or nicotine, the predominant component of cigarettes) protects pregnant women against pre-eclampsia. Pre-eclampsia, also known as ‘pregnancy induced hypertension,’ affects between 5-8% of all pregnant women. Pre-eclampsia is characterized by a potentially harmful increase in blood pressure, swelling, and protein in the urine (as a result of kidney damage) and poor birth outcome. The cause of pre-eclampsia is not known. However, numerous studies show that abnormal chemical factors within the placenta play an important role in pre-eclampsia and that women who smoke during their pregnancy are less likely to develop pre-eclampsia or pregnancy-induced hypertension. The expelled placenta is normally discarded. For this study, we would like to collect placentas obtained from both smokers and non-smokers to study the effects of smoking (or nicotine added to placental cells in the laboratory) on the inflammatory responses by the placenta.
Eligibility Criteria
Women who have given birth at North Shore University Hospital Manhasset - non-smokers and smokers
Primary Investigator(s)
- Burton Rochelson, MD